发明名称 |
METHYLGLYOXAL AS A MARKER OF CANCER |
摘要 |
A reliable, sensitive and easy to handle diagnostic and prognostic test of cancer, includes measuring and analyzing the production of methylglyoxal (MG) from metabolically active cancer cells; in biological samples of extracellular fluids, cells and/or tissues of human or animal subjects. It uses any chemical or immunological in vitro method for MG measurement and it provides a kit for the early detection, screening and diagnosis of cancer; for the staging of cancer, for predicting the survival odds of cancer patients, for monitoring therapeutic response to anticancer programs (including prevention and prophylactic treatments), and for prediction and early detection of cachexia. |
申请公布号 |
US2015301056(A1) |
申请公布日期 |
2015.10.22 |
申请号 |
US201314437911 |
申请日期 |
2013.10.25 |
申请人 |
ASSOCIATION POUR LA RECHERCHE THERAPEUTIQUE ANTI-CANCEREUSE |
发明人 |
Belpomme Dominique;Irigaray Philippe |
分类号 |
G01N33/574;G01N33/66 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for the early detection and diagnosis of cancer by measuring and analyzing the in situ production of methylglyoxal (MG) by metabolically active cancer cells in samples of cells and/or of tissues, by using any chemical or immunological in vitro methods of MG measurement. |
地址 |
Paris FR |